Review



hemochron whole blood micro-coagulation system  (Accriva Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Accriva Inc hemochron whole blood micro-coagulation system
    Hemochron Whole Blood Micro Coagulation System, supplied by Accriva Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optimized+multi-parameter+mapping+sequence/whole+blood+microcoagulation+system+hemochron/us11968974-453-7-12
    Average 90 stars, based on 1 article reviews
    hemochron whole blood micro-coagulation system - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Recovery of extracorporeal lungs using cross-circulation with injured recipient swine.
    Article Snippet: Objective: Lung transplantation remains limited by the shortage of healthy organs.. Cross-circulation with a healthy swine recipient provides a durable physiologic environment to recover injured donor lungs.. In a clinical application, a recipient awaiting lung transplantation could be placed on cross-circulation to recover damaged donor lungs, enabling eventual transplantation.

    Article Title: Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs.
    Article Snippet: 1Department of Biomedical Engineering, Columbia University, New York, NY, USA.. 2Department of Surgery, Columbia University Medical Center, Columbia University, New York, NY, USA.. 3Institute of Comparative Medicine, Columbia University Medical Center, Columbia University, New York, NY, USA.

    Article Title: Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs
    Article Snippet: Activated clotting time was measured using a whole blood micro-coagulation system (Hemochron; Accriva Diagnostics), and the heparin drip was adjusted to maintain activated clotting times within the target range of 250 – 350 s. Physiological parameters of the swine host, including heart rate, electrocardiogram, blood pressure (cuff and arterial line pressure), mean arterial pressure (MAP), oxygen saturation (SpO 2 ), end-tidal CO 2 , temperature, and respiratory rate, were continuously monitored and recorded ( Supplementary Table 2 ) using a multi-parameter vital signs monitor (SurgiVet).

    Article Title: Xenogeneic cross-circulation for physiological support and recovery of ex vivo human livers
    Article Snippet: Activated clotting time was measured using a whole-blood microcoagulation system (Hemochron; Accriva Diagnostics), and the heparin infusion was titrated to an activated clotting time of 180–250 seconds.

    Article Title: Immune characterization of a xenogeneic human lung cross-circulation support system.
    Article Snippet: Activated clotting time (ACT) was measured using a whole-blood microcoagulation system (Hemochron, Accriva Diagnostics), and the heparin infusion was adjusted to maintain ACTs within the target range of 180 to 250 s. Physiological parameters of the xenosupport swine, including heart rate, electrocardiogram, arterial blood pressure, oxygen saturation (SpO2), temperature, and respiratory rate were continuously monitored and recorded (figs. S3 and S4) using a multiparameter vital signs monitor (SurgiVet).

    Article Title: Immune characterization of a xenogeneic human lung cross-circulation support system
    Article Snippet: Activated clotting time (ACT) was measured using a whole-blood microcoagulation system (Hemochron, Accriva Diagnostics), and the heparin infusion was adjusted to maintain ACTs within the target range of 180 to 250 s. Physiological parameters of the xeno-support swine, including heart rate, electrocardiogram, arterial blood pressure, oxygen saturation (SpO 2 ), temperature, and respiratory rate were continuously monitored and recorded (figs. S3 and S4) using a multiparameter vital signs monitor (SurgiVet).

    Article Title: Cross-circulation platform for recovery, regeneration, and maintenance of extracorporeal organs
    Article Snippet: Activated clotting time was measured using a HemoChron whole blood micro-coagulation system (Accriva Diagnostics), and the heparin drip was adjusted to maintain a target value of 250-350 s. Physiological parameters of the recipient, including heart rate, electrocardiogram, blood pressure (cuff and arterial A-line pressure), mean arterial pressure (MAP), oxygen saturation (SpO2), end-tidal CO2, temperature, and respiratory rate, were continuously monitored and recorded using a multi-parameter Advisor vital signs monitor (SurgiVet).

    Coagulation:


    Ex Vivo:


    Sterility:




    Similar Products

    optimized multi-parameter mapping sequence  (Respiratory Motion)
    90
    Respiratory Motion optimized multi-parameter mapping sequence
    Optimized Multi Parameter Mapping Sequence, supplied by Respiratory Motion, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optimized+multi-parameter+mapping+sequence/optimized+multi+parameter+mapping+sequence/pm37946191-138-14-4
    Average 90 stars, based on 1 article reviews
    optimized multi-parameter mapping sequence - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results